Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 3
1987 2
1988 2
1989 7
1990 3
1991 2
1992 1
1993 4
1994 1
1995 10
1996 4
1997 7
1998 5
1999 13
2000 7
2001 5
2002 9
2003 11
2004 13
2005 6
2006 10
2007 17
2008 9
2009 19
2010 24
2011 19
2012 14
2013 30
2014 34
2015 30
2016 22
2017 21
2018 18
2019 22
2020 29
2021 14
2022 21
2023 27
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

455 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Elevated cancer Ag 19-9 level"
Page 1
CA 19-9: Biochemical and Clinical Aspects.
Scarà S, Bottoni P, Scatena R. Scarà S, et al. Adv Exp Med Biol. 2015;867:247-60. doi: 10.1007/978-94-017-7215-0_15. Adv Exp Med Biol. 2015. PMID: 26530370 Review.
Normally synthesized by normal human pancreatic and biliary ductal cells and by gastric, colon, endometrial and salivary epithelia, CA 19-9 is present in small amounts in serum, and can be over expressed in several benign gastrointestinal disorders. ...In add …
Normally synthesized by normal human pancreatic and biliary ductal cells and by gastric, colon, endometrial and salivary epithelia, CA …
The clinical significance of elevated levels of serum CA 19-9.
Pavai S, Yap SF. Pavai S, et al. Med J Malaysia. 2003 Dec;58(5):667-72. Med J Malaysia. 2003. PMID: 15190651 Free article.
The tumour marker CA19-9 is a sensitive marker for pancreatic, gastric and hepatobiliary malignancies. High CA 19-9 level indicates unresectable lesions and a poor prognosis. ...In conclusion, elevated CA 19-9 may be …
The tumour marker CA19-9 is a sensitive marker for pancreatic, gastric and hepatobiliary malignancies. High CA 19-9 …
Prediction Model for Early-Stage Pancreatic Cancer Using Routinely Measured Blood Biomarkers.
Boyd LNC, Ali M, Comandatore A, Garajova I, Kam L, Puik JR, Fraga Rodrigues SM, Meijer LL, Le Large TYS, Besselink MG, Morelli L, Frampton A, van Laarhoven HWM, Giovannetti E, Kazemier G. Boyd LNC, et al. JAMA Netw Open. 2023 Aug 1;6(8):e2331197. doi: 10.1001/jamanetworkopen.2023.31197. JAMA Netw Open. 2023. PMID: 37639271 Free PMC article.
IMPORTANCE: Accurate risk prediction models using routinely measured biomarkers-eg, carbohydrate antigen 19-9 (CA19-9) and bilirubin serum levels-for pancreatic cancer could facilitate early detection of pancreatic cancer and prevent potentially unnecessary diagnost …
IMPORTANCE: Accurate risk prediction models using routinely measured biomarkers-eg, carbohydrate antigen 19-9 (CA19-9) and bil …
Dilemma of elevated CA 19-9 in biliary pathology.
Tsen A, Barbara M, Rosenkranz L. Tsen A, et al. Pancreatology. 2018 Dec;18(8):862-867. doi: 10.1016/j.pan.2018.09.004. Epub 2018 Sep 18. Pancreatology. 2018. PMID: 30249386 Review.
Carbohydrate antigen 19-9 (CA 19-9) is a tumor marker which has been extensively evaluated and widely utilized primarily in diagnosing and prognosticating pancreaticobiliary malignancies. ...These studies have demonstrated that many factors infl …
Carbohydrate antigen 19-9 (CA 19-9) is a tumor marker which has been extensively evaluated and widely utilized p …
Carbohydrate antigen 19-9 for differential diagnosis of pancreatic carcinoma and chronic pancreatitis.
Su SB, Qin SY, Chen W, Luo W, Jiang HX. Su SB, et al. World J Gastroenterol. 2015 Apr 14;21(14):4323-33. doi: 10.3748/wjg.v21.i14.4323. World J Gastroenterol. 2015. PMID: 25892884 Free PMC article. Review.
AIM: To evaluate the utility of carbohydrate antigen 19-9 (CA19-9) for differential diagnosis of pancreatic carcinoma and chronic pancreatitis. ...The area under the ROC curve was 0.88. No significant publication bias was detected. CONCLUSION: Elevated CA19-9 by its …
AIM: To evaluate the utility of carbohydrate antigen 19-9 (CA19-9) for differential diagnosis of pancreatic carcinoma and chronic pan …
Serum carbohydrate antigen 19-9 in pancreatic adenocarcinoma: a mini review for surgeons.
Goh SK, Gold G, Christophi C, Muralidharan V. Goh SK, et al. ANZ J Surg. 2017 Dec;87(12):987-992. doi: 10.1111/ans.14131. Epub 2017 Aug 13. ANZ J Surg. 2017. PMID: 28803454 Review.
The optimal management of oncological conditions is reflected by the careful interpretation of investigations for screening, diagnosis, staging, prognostication and surveillance. Serum tumour markers are examples of commonly requested tests in conjunction with other imagin …
The optimal management of oncological conditions is reflected by the careful interpretation of investigations for screening, diagnosis, stag …
EGFR is a potential therapeutic target for highly glycosylated and aggressive pancreatic neuroendocrine neoplasms.
Xiao Z, Xu H, Strosberg JR, Lu R, Zhu X, Deng S, Ding L, Ni Q, Warshaw AL, Yu X, Luo G. Xiao Z, et al. Int J Cancer. 2023 Jul 1;153(1):164-172. doi: 10.1002/ijc.34499. Epub 2023 Mar 17. Int J Cancer. 2023. PMID: 36891979
The molecular and metabolic features stratified by glycosylation status were assessed by RNA-seq/whole exome sequencing and immunohistochemistry. A considerable proportion of patients had elevated glycosylation biomarkers (carbohydrate antigen [CA] 19- …
The molecular and metabolic features stratified by glycosylation status were assessed by RNA-seq/whole exome sequencing and immunohistochemi …
An elevated CA 19-9 is associated with invasive cancer and worse survival in IPMN.
Ciprani D, Morales-Oyarvide V, Qadan M, Hank T, Weniger M, Harrison JM, Rodrigues C, Horick NK, Mino-Kenudson M, Ferrone CR, Warshaw AL, Lillemoe KD, Fernández-Del Castillo C. Ciprani D, et al. Pancreatology. 2020 Jun;20(4):729-735. doi: 10.1016/j.pan.2020.04.002. Epub 2020 Apr 15. Pancreatology. 2020. PMID: 32332003
BACKGROUND: Current guidelines for IPMN include an elevated serum carbohydrate antigen (CA) 19-9 among the worrisome features. ...The proportion of concurrent pancreatic cancer was higher in patients with CA 19-9 > 37 U/m …
BACKGROUND: Current guidelines for IPMN include an elevated serum carbohydrate antigen (CA) 19-9 among th …
Carbohydrate antigen 19-9 plus carcinoembryonic antigen for prognosis in colorectal cancer: An observational study.
Lee JO, Kim M, Lee JH, Kim Y, Lim HK, Kwon YH, Shin R, Park JW, Ryoo SB, Park KJ, Jeong SY. Lee JO, et al. Colorectal Dis. 2023 Feb;25(2):272-281. doi: 10.1111/codi.16372. Epub 2022 Oct 27. Colorectal Dis. 2023. PMID: 36226485
Carbohydrate antigen 19-9 (CA 19-9) can be used as a supplemental tumour marker along with CEA. The purpose of this study was to determine whether preoperative CA 19-9 added to CEA helped predict long-term prognosis a …
Carbohydrate antigen 19-9 (CA 19-9) can be used as a supplemental tumour marker along with CEA. The purpose of t …
Elevated CA 19-9 is associated with worse survival in patients with resected ampullary adenocarcinoma.
Boyev A, Prakash LR, Chiang YJ, Newhook TE, Bruno ML, Arvide EM, Dewhurst WL, Kim MP, Ikoma N, Lee JE, Snyder RA, Tzeng CD, Katz MHG, Maxwell JE. Boyev A, et al. Surg Oncol. 2023 Dec;51:101994. doi: 10.1016/j.suronc.2023.101994. Epub 2023 Sep 19. Surg Oncol. 2023. PMID: 37742542
BACKGROUND: The prognostic utility of Carbohydrate Antigen 19-9 (CA 19-9) and Carcinoembryonic Antigen (CEA) in ampullary adenocarcinoma is unclear. ...CA 19-9 may be useful when counseling patients about prognosis …
BACKGROUND: The prognostic utility of Carbohydrate Antigen 19-9 (CA 19-9) and Carcinoembryonic Antigen …
455 results